HCPCS J9271 — Inj pembrolizumab (2026 RVU Values)
HCPCS code J9271 (Inj pembrolizumab) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.
HCPCS code J9271 (Inj pembrolizumab) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.